PROLIEVE THERMODILATATION SYSTEM

System, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy

FDA Premarket Approval P030006

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval the prolieve thermodilatation system, which is a transurethral microwave therapy device that provides a non-surgical, minimally invasive procedure for the treatment of symptomatic bhp in men with a prostate size of 20 to 80 grams, a prostatic urethra length of 1. 2 to 5. 5 cm and in whom drug therapy (e. G. , proscar) in typically indicated.

DevicePROLIEVE THERMODILATATION SYSTEM
Classification NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
Generic NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
ApplicantMEDIFOCUS, INC
Date Received2003-03-24
Decision Date2004-02-19
Notice Date2004-03-09
PMAP030006
SupplementS
Product CodeMEQ
Docket Number04M-0116
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address MEDIFOCUS, INC 10240 Old Columbia Road suite G columbia, MD 21046
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P030006Original Filing
S028 2018-03-30 Normal 180 Day Track No User Fee
S027 2014-11-18 30-day Notice
S026 2014-05-21 135 Review Track For 30-day Notice
S025 2012-04-23 30-day Notice
S024 2010-12-23 Normal 180 Day Track No User Fee
S023 2010-01-13 30-day Notice
S022 2009-04-02 Normal 180 Day Track
S021 2009-01-16 135 Review Track For 30-day Notice
S020 2008-11-14 30-day Notice
S019 2008-07-01 Real-time Process
S018 2008-06-05 135 Review Track For 30-day Notice
S017 2008-02-12 Normal 180 Day Track
S016 2007-09-28 30-day Notice
S015 2007-06-14 30-day Notice
S014 2007-06-13 Real-time Process
S013 2007-04-23 Normal 180 Day Track No User Fee
S012 2006-11-21 Real-time Process
S011 2006-06-26 Real-time Process
S010 2005-12-01 Normal 180 Day Track No User Fee
S009 2005-11-21 Normal 180 Day Track
S008 2005-11-18 Normal 180 Day Track
S007 2005-09-12 30-day Notice
S006 2005-05-31 Real-time Process
S005 2005-03-23 Normal 180 Day Track No User Fee
S004 2005-01-28 Real-time Process
S003 2004-10-01 Normal 180 Day Track No User Fee
S002 2004-08-18 Real-time Process
S001 2004-03-11 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.